With the Us market for blood plasma appearing soft, CSL will be anxious to leverage of its pipeline to make up any profit deficiencies.
We are all expecting news on the CSL collaboration and I believe the timing for POH could not be better if we get any positive news on the CSL front.
csl biotherapies
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.923M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 35 | 43869108 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 44263580 | 22 |
View Market Depth
| Last trade - 16.12pm 04/10/2024 (20 minute delay) ? |
| AVE (ASX) Chart |
Day chart unavailable